Lunit Revenue and Competitors
Estimated Revenue & Valuation
- Lunit's estimated annual revenue is currently $72M per year.
- Lunit's estimated revenue per employee is $251,000
Employee Data
- Lunit has 287 Employees.
- Lunit grew their employee count by 57% last year.
Lunit's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder, Executive Chairman | Reveal Email/Phone |
2 | Co-founder, Chief Product, and Regulation Division Officer | Reveal Email/Phone |
3 | Global VP Pharma Business Development, Oncology | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | Head BD&S | Reveal Email/Phone |
6 | VP Business Development | Reveal Email/Phone |
7 | VP Research, Cancer Screening Group | Reveal Email/Phone |
8 | VP Regulation | Reveal Email/Phone |
9 | Director Commercial Sales | Reveal Email/Phone |
10 | Chief Business Officer, Group Head Oncology Group | Reveal Email/Phone |
Lunit Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Lunit?
Lunit, abbreviated from “learning unit,†is a Medical AI software company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology. Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Lunit is based in Seoul, South Korea.
keywords:N/AN/A
Total Funding
287
Number of Employees
$72M
Revenue (est)
57%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lunit News
Findings from the study validate the effectiveness of Lunit SCOPE IOLunit's AI biomarkerin predicting clinical outcomes of immunotherapy...
SEOUL, South Korea, April 27, 2022 /PRNewswire/ -- Lunit, a leading medical AI provider, today announced it has received the CE-IVDD Mark...
The Seoul-based artificial intelligence startup Lunit has received a preliminary green light for an IPO on the South Korean Kosdaq market,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $87.1M | 307 | 4% | N/A |
#2 | $59.8M | 330 | 61% | N/A |
#3 | $3.5M | 341 | 9% | N/A |
#4 | $63.4M | 350 | 11% | N/A |
#5 | $90.7M | 354 | -7% | N/A |